Center for Research in Emerging Infectious Diseases in East and Central Africa Plus
Official title: CENTER FOR RESEARCH IN EMERGING INFECTIOUS DISEASES- EAST AND CENTRAL AFRICA PLUS
Funded at Washington State University · NIH-11601585 · Data updated 2026-11-12
A center-led effort to study and respond to emerging infectious diseases in East and Central Africa, with collaboration in the region and Central America.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington State University NIH-funded |
| Lab location | 1 site (Pullman, United States) |
| Project start | August 1, 2020 |
| Project end | June 30, 2031 |
| Funding year | 2026 |
| Award (this year) | $91,056 |
| NIH project number | 3U01AI151799-06S2 |
| Project ID | NIH-11601585 on NIH RePORTER |
Who could benefit from this research
✓Could help
Researchers, clinicians, and communities in East and Central Africa who participate in outbreak response studies, clinical observations, and biospecimen collection.
✕Less likely to help
Individuals not involved in outbreak response activities or not from the study regions may not directly benefit.
What this research studies
This center builds on prior work to study outbreaks like COVID-19, Rift Valley fever, Sudan ebolavirus, Marburg, and Mpox, using clinical, immune, and social science approaches. Researchers will continue rapid outbreak response research to understand pathogens, transmission, and public health needs. The project also supports training and mentorship of researchers, with a track record of publishing findings to inform prevention and control. The work aims to improve how outbreaks are detected, characterized, and managed in affected communities.
Why it matters
Potential benefit: If successful, the program could improve outbreak preparedness, disease understanding, and local capacity for rapid response in East and Central Africa and nearby regions.
How similar studies have gone: Past rounds produced multiple manuscripts and several funded grants, indicating productive and impactful research in regional outbreak settings.
Where this research is happening
-
Washington State University
Pullman, United States Active
Researchers
- Principal investigator: Njenga, M Kariuki — Washington State University
- Study coordinator: Njenga, M Kariuki
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.